Introduction
F����� ����� ��� ���������� �������� �� ����������c �����-nancies and soft tissue sarcomas (1) . These fusion genes are ������� ����c����� w��� c��������� ������������� ��c� �� �������c������, ����������, ��� ���������, ��� ���� ���� ���� identified in cryptic chromosome abnormalities. Fusion genes have also been identified in various solid tumors, including ETS-family fusion genes in prostate cancer (2) , ETV6-NTRK3 in secretory breast cancer (3) , and ALK ������ ����� �� ���� cancer (4) . Many of these fusion genes create in-frame fusion �����c��p�� ���� ������ �� ��� p����c���� �� ������ p�������, ��� ���� �� w��c� ��� �������������. T���� ������ p������� ��� ����� ����c����� w��� ������� p������p� ��� c����c�� ���c���, ��� �c� �� ���k��� ��� ������� �������� ������� ��� ����c����� �� �����p����c �������. H�w����, ������� ������ ����� ���� �� ��� c����� ��-����� ������ �����c��p�� ���� ���� ���� ������-fied. Oncogenic rearrangements of immunoglobulin (IG) �� T-cell receptor (TCR) ����� ��� w���-k��w� ������ �����, ��� ���� �� ����� c����� ������ �����c��p��, ��c� �� IGH-BACH2 by t(6;14)(q15;q32) in B-cell lymphoma/leukemia (5), IGH-MMSET by t(4;14)(p16.3;q32.3) (6) and Cα-IRTA1 �� t(1;14)(q21;q32) (7) in multiple myeloma, and BCL11B-TRDC by inv(14)(q11.2q32.31) in T-cell acute lymphoblastic leukemia (8) . Furthermore, chromosome abnormalities led to fusion �����c��p�� �� ��� ���-c����� ���� PVT1 ��c� �� PVT1-NBEA ��� PVT1-WWOX in multiple myeloma (9) , PVT1-CHD7 �� small-cell lung carcinoma (10) , and PVT1-MYC ��� PVT1-NDRG1 in medulloblastoma (11) . The role of PVT1-������� �� ��c������, ��� ���� ��� ��p������ ������� ��p� �� ������ �����c��p� �� c��c�� c���� ��� p������� �� ������ c����.
In the present study, we unexpectedly identified additional fusion genes involving 28S ribosomal DNA (RN28S1) �� ����������c ��������c���. cDNA bubble PCR. cDNA bubble PCR was used to detect the ������ p������ �� BCL11B, as described previously ( Fig. 1 ) (12) . Total RNA was used to generate double-stranded cDNA. Primers used were: NVAMP-1 and BCL11B-4A for first-round PCR, and NVAMP-2 and BCL11B-3A-1 for second-round PCR ( Fig. 1 and Table I ).
Materials and methods

Clinical
Reverse transcription (RT)-PCR.
RT-PCR analysis was performed as described previously (5). Primers used for ��� ����c���� �� BCL11B-RN28S1 ������ �����c��p�� w��� BCL11B-3A-2 and RN28S1-GA1 for first-round PCR, and BCL11B-3A-1 and RN28S1-GA2 for second-round PCR; ����� ��� IGKV3-20-RN28S1 were IGKV3-20-2F and 
RN28S1-GA1; and those for COG1-RN28S1 w��� COG1-11F and RN28S1-GA1 (Table I) .
Nucleotide sequencing. Nucleotide sequences of PCR products and, if necessary, subcloned PCR products were analyzed as previously described (5).
Results
Identification of RN28S1-BCL11B fusion transcript by cDNA bubble PCR method. L��k���c c���� ���� � p������ w��� mixed-lineage acute leukemia having t(6;14)(q25;q32) were analyzed using fluorescence in situ hybridization analysis, ��� ������������� �� ��� B-c��� ���k����/���p���� 11B (BCL11B) gene was suggested (Fig. 2) . Thus, we performed cDNA bubble PCR to identify the gene on chromosome 6q25 ���� w�� ����� �� ��� BCL11B gene on 14q32. Sequence �������� �� �����p�� p����c�� ��p������ �� ��c���-����� PCR of bubble PCR detected a product that contained a 34-�p ������c� �� BCL11B �x�� 3 ����� �� �� ��k��w� 96-bp sequence (Fig. 3A) . A BLAST search revealed that the unknown sequence was 28S ribosomal DNA (RN28S1) ( Fig. 4A ). This fusion transcript was confirmed by RT-PCR (Fig. 3B) . The transcriptional directions of the contributing ����� �� ��� ������ �����c��p� w��� �pp����, ��� ��� ������ p���� �� BCL11B was within the exon (Fig. 4A) . No sequences from chromosome 6q25 were identified. (Fig. 4B) . The multiple myeloma cell line KMS-18, amplified multiple PCR products (Fig. 3D ) including a 441-bp product that resulted from a 62-bp sequence of the component of oligomeric Golgi complex 1 (COG1) ���� ����� �� �� RN28S1 sequence (Fig. 4C ). These fusions both �cc����� w����� ��� �x��� �� IGKV3-20 ��� COG1, �� �� ��� RN28S1-BCL11B fusion, and they were confirmed by RT-PCR using each specific primer ( Fig. 3E and F) . C��p������ �� ��� ������c� �� BCL11B p����� w��� ����� �� IGKV3-20 ��� COG1 ����� ������������ ���w��� ����, w��� ��x ������c��� �� 20 ��c��������, ���������� ���� ��������� �� ��� p����� �� ��� ������� ������c�� �� IGK ��� COG1 ���� it possible to amplify these fusion genes by chance (Fig. 5) . Other products amplified by RT-PCR for the detection of RN28S1-BCL11B w��� ������ ��� ������ ������c� �� RN28S1 or non-specific sequences.
Discussion
In the present study, we identified three novel fusion transcripts ��������� RN28S1. O��� ��� RN28S1-������� ������ ����, RN28S1-BCL6, ��� ���� p��������� ��p�����, ��� ���� w�� �� a case of gastric lymphoma (13) . RN28S1 �� � ���� ���� w���� ��� ��������� �� p������, ��� ��� ����kp����� �� p������ ����� �� RN28S1 w��� w����� ��� c����� �x���. N������, BCL11B ��� RN28S1 w��� ����� w��� �pp����� �����c��p���� ����c�����. These findings suggest that fusion genes involving RN28S1 �� ��� p����c� ������ p�������, ��� ���� �����p���� �� ��� ������ ���c����� �� ������ p������� c��������� �� ������������� �� ����� c����.
Several studies have noted an association of ribosomal DNA (RNA) with tumorigenesis. rRNA transcription and �������� ���������� ��� c��������� �� ������� c��c��-������� genes through the PI3 kinase/mTOR, MYC or RAS/ERK pathways (14) . Proto-oncoprotein MYC controls ribosome ���������� ������� ��� ���������� �� �����c��p���� �� ��� three RNA polymerases (15) . Another cancer-related gene, nucleophosmin (NPM1), w��c� �� ���������� ������� �� �c��� ������� ���k���� w��� � ������ k������p� ��� c������ ������ ����� w��� ALK in anaplastic large cell lymphoma with t(2;5) (p23;q35), is necessary for MYC-mediated rRNA synthesis (16) . RN28S1 has three MYC-binding sites (17) , and the breakp����� w����� RN28S1 in our cases were to the 5' side of the MYC-binding sites (Fig. 6) , suggesting that the RN28S1-������ �����c��p�� w� ����c��� ��� ����c����� w��� ������������� ������� ��� ������������� �� MYC-�������� �RNA ���������. In other correlations of rDNA with tumorigenesis, a high frequency of rDNA rearrangements was noted in lung and colon cancers (18) and overexpression of rDNA was seen in prostatic cancer (19) . The breakpoints of RN28S1 �� ��� ����� cases were within an ~600 bp region (Fig. 6) ; these may be ������� �� ��c������������ ��� �p��� �� ��p������� ������c��.
T�� ����� ����� ����� �� RN28S1 ���� w� ����� �� ��� ����� ��� ������� �� ������������� �� c������ ��p�� �� ��������c���. IGK �� ��� �� ��� �������������� ����� c���� ����� ���� �� ���������� ���������� �� c��������� �������-cations, such as t(2;8)(p11;q24) in B-cell malignancies (20) . R������������ �� ��� BCL11B ���� ��c�� �� �������� �� T-c��� ��������c���, ��� ����� ������ �����c��p�� ��������� BCL11B have been identified: TLX3-BCL11B ������ ���� �� c��p��c t(5;14)(q35;q32.2) in T-ALL (21), BCL11B-TRDC by inv(14) (q11.2q32.31) in T-ALL (8) and HELIOS-BCL11B by t(2;14) (q34;q32) in adult T-cell leukemia (22) . COG1 �� � c��p����� of the conserved oligomeric Golgi (COG) complex, Golgi �����p��� c��p��x, ���� �� �������� �� ���c��������� ���c����� and vesicular transport (23) . Although the COG1 ���� ��� ��� been firmly associated with tumorigenesis to date, one COG ������ ����, COG5, w�� ����� ����� �� HMGA2 �� ������� leiomyoma (24) , suggesting a possible link with tumorigenesis. Although the fusion genes we identified in this study were not ������� �� c��������� �������c������, ��c� ���� �� �������� �� ������������� �� ���� w��, ���������� ���� RN28S1-������� ������ ����� p��� ���� ����� �� �������������.
Molecular analysis of ribosomal DNA is challenging due to its repetitive nature. In this study, we attempted to confirm the three fusions at the genomic level; however, genomic PCR w�� ����cc������. A p������� �xp�������� ��� ��� ������� �� amplification of genomic junctions is the quantitative imbalance of genomic DNAs between partner genes and RN28S1 due to the ~400 copies of ribosomal DNA in a diploid human ������. W����-�����c��p���� �������� �� ��x�-���������� ������c��� �� ������� � p�w����� ���� ��� ��� ����c���� �� ������ �����c��p��. H�w����, ����c���� �� RN28S1 ������ �����c��p�� using this method is difficult, because ribosomal RNAs, which comprises >95% of total RNA, is usually removed from total RNA p���� �� ������c���. W���� ������� �������� �� ������ �� clarify the role of rDNA in tumorigenesis, our findings provide an important insight into the role of rDNA function in human ������c ��c����c���� ��� �������������.
